Annual Accounts Payable
$17.73 M
+$13.94 M+368.30%
December 31, 2023
Summary
- As of February 7, 2025, HRMY annual accounts payable is $17.73 million, with the most recent change of +$13.94 million (+368.30%) on December 31, 2023.
- During the last 3 years, HRMY annual accounts payable has risen by +$15.17 million (+593.66%).
- HRMY annual accounts payable is now at all-time high.
Performance
HRMY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.53 M
-$12.15 M-53.57%
September 30, 2024
Summary
- As of February 7, 2025, HRMY quarterly accounts payable is $10.53 million, with the most recent change of -$12.15 million (-53.57%) on September 30, 2024.
- Over the past year, HRMY quarterly accounts payable has dropped by -$7.20 million (-40.60%).
- HRMY quarterly accounts payable is now -53.57% below its all-time high of $22.68 million, reached on June 30, 2024.
Performance
HRMY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
HRMY Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +368.3% | -40.6% |
3 y3 years | +593.7% | +152.0% |
5 y5 years | +1112.7% | - |
HRMY Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1671.2% | -53.6% | +952.1% |
5 y | 5-year | at high | +1671.2% | -53.6% | +952.1% |
alltime | all time | at high | +1671.2% | -53.6% | +952.1% |
Harmony Biosciences Holdings Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $10.53 M(-53.6%) |
Jun 2024 | - | $22.68 M(+49.8%) |
Mar 2024 | - | $15.14 M(-14.6%) |
Dec 2023 | $17.73 M(+368.3%) | $17.73 M(+171.1%) |
Sep 2023 | - | $6.54 M(-0.4%) |
Jun 2023 | - | $6.56 M(+2.3%) |
Mar 2023 | - | $6.41 M(+69.4%) |
Dec 2022 | $3.79 M | $3.79 M(-62.3%) |
Sep 2022 | - | $10.05 M(+50.9%) |
Jun 2022 | - | $6.66 M(-3.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $6.90 M(+589.7%) |
Dec 2021 | $1.00 M(-60.8%) | $1.00 M(-76.0%) |
Sep 2021 | - | $4.18 M(+108.3%) |
Jun 2021 | - | $2.01 M(-54.3%) |
Mar 2021 | - | $4.39 M(+71.8%) |
Dec 2020 | $2.56 M(-59.8%) | $2.56 M(-72.7%) |
Sep 2020 | - | $9.35 M(+350.9%) |
Jun 2020 | - | $2.07 M(-57.3%) |
Mar 2020 | - | $4.85 M(-23.7%) |
Dec 2019 | $6.36 M(+335.0%) | $6.36 M |
Dec 2018 | $1.46 M | - |
FAQ
- What is Harmony Biosciences Holdings annual accounts payable?
- What is the all time high annual accounts payable for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual accounts payable year-on-year change?
- What is Harmony Biosciences Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly accounts payable year-on-year change?
What is Harmony Biosciences Holdings annual accounts payable?
The current annual accounts payable of HRMY is $17.73 M
What is the all time high annual accounts payable for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual accounts payable is $17.73 M
What is Harmony Biosciences Holdings annual accounts payable year-on-year change?
Over the past year, HRMY annual accounts payable has changed by +$13.94 M (+368.30%)
What is Harmony Biosciences Holdings quarterly accounts payable?
The current quarterly accounts payable of HRMY is $10.53 M
What is the all time high quarterly accounts payable for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly accounts payable is $22.68 M
What is Harmony Biosciences Holdings quarterly accounts payable year-on-year change?
Over the past year, HRMY quarterly accounts payable has changed by -$7.20 M (-40.60%)